Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenalin versus Midodrine + Octreotide in Hepatorenal Syndrome
IRCT201107217085N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Isfahan University of Medical Sciences
- Start
- Sep 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of norepinephrine, midodrine and octreotide in hepatorenal syndrome type 1 (HRS-1) and hepatorenal syndrome type 2 (2 arms), sponsored by Vice Chancellor for Research of Isfahan University of Medical Sciences. Primary endpoint: renal_function_improvement. Started Sep 2011; status: completed.
02
Drugs
norepinephrinemidodrineoctreotide
03
Conditions
hepatorenal syndrome type 1 (HRS-1)hepatorenal syndrome type 2
Beyond the preview
Go deeper on IRCT201107217085N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201107217085N1.